Tissue-engineered skin substitutes.
The last two years have seen new tissue-engineered skin substitutes come onto the market and begin to resolve the various roles to which each is best suited. It is becoming evident that some of the very expensive cell-based products have cost-benefit advantage despite their high price and are valuable within the restricted applications for which they are intended. The use of skin substitutes for testing purposes has extended from epidermal keratinocytes to other integumentary epithelia and into preparations containing multiple cell types in which reactions resulting from paracrine interactions can be examined. Challenges remain in the application of gene therapy techniques to skin substitutes, both the control of transgene expression and in the selection of suitable genes to transfect. A coming challenge is the production of tissue-engineered products without the use of animal products other than human cells. A challenge that may be diminishing is the importance of acute rejection of allogeneic tissue-engineered skin substitutes.
Mansbridge
Jonathan
J
Advanced Tissue Sciences, 10933 North Torrey Pines Road, La Jolla, CA 92037, USA. jonathan.mansbridge@advancedtissue.com
D000818:Animals; D001698:Biomedical Engineering; D006801:Humans; D008422:Materials Testing; D017768:Skin, Artificial / Q000009:adverse effects / Q000592:standards